Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2026-04-02 @ 3:24 PM
Study NCT ID:
NCT05555732
Status:
RECRUITING
Last Update Posted:
2025-09-11
First Post:
2022-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
Sponsor:
Organization: